opc 12759 has been researched along with Mouth Neoplasms in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasuda, T | 1 |
| Chiba, H | 1 |
| Satomi, T | 1 |
| Matsuo, A | 1 |
| Kaneko, T | 1 |
| Miyamatsu, H | 1 |
1 trial available for opc 12759 and Mouth Neoplasms
| Article | Year |
|---|---|
[A pilot study of rebamipide-gargle for chemoradiotherapy-induced mucositis in oral cancer patients].
Topics: Aged; Aged, 80 and over; Alanine; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; | 2008 |